GGrantIndex
Sort

130,381 grants matching hiv

AWI-Gen Phase 2: Genomic and environmental risk factors for cardiometabolic disease in Africans

$1,179,963
Michele Michele Ramsay · Wits Health Consortium (Pty), Ltd · U54 · FY2017 · HG

Role of HIV Envelope Proteins In Viral Replication and HIV Pathogenesis

$1,179,888
Anthony S. Fauci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI

Interaction of HIV envelope with cell surface receptors

$1,179,888
Anthony S. Fauci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI

Synthesis of Therapeutic Agents for Treatment of Infectious Diseases

$1,179,826
David Starks · Starks Associates, Inc. · N01 · FY2014 · AI

The Johns Hopkins University-Blantyre Clinical Trials Unit

$1,179,653
Taha E Taha · Johns Hopkins University · UM1 · FY2016 · AI

Search for the Structural Basis of Biomacromolecular Function and Activity

$1,179,569
Yun Xing M Wang · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

An unbiased OMICs approach to identify mechanisms of Cocaine regulation of the HIV reservoir.

$1,179,414
Rafick-Pierre Sekaly · Case Western Reserve University · R01 · FY2018 · DA

Factors Influencing Genetic Transcription Initiation And Termination

$1,179,326
Robert J Crouch · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2011 · HD

Texas NeuroAIDS Research Center

$1,179,094
Benjamin B. Gelman · University Of Texas Med Br Galveston · U24 · FY2013 · MH

Center for Interdisciplinary Research on AIDS

$1,178,985
Paul D Cleary · Yale University · P30 · FY2007 · MH

Building Opportunities for Nurturing care to enhance Development in Eastern and Southern Africa (BONDS)

$1,178,860
Christine Jennifer McGrath · University Of Washington · U19 · FY2025 · HD

Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in Lymphoma

$1,178,618
Douglas F Nixon · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · CA

Ethno-epidemiology of HCV, HIV and Overdose associated with Drug Markets and Drug Tourism

$1,178,536
Steffanie A Strathdee · University Of California, San Diego · R01 · FY2024 · DA

SUPPORT THE IMPLEMENTATION AND EXPANSION OF HIGH QUALITY HIV PREVENTION, CARE AND

$1,178,393
Aabid Ahmed · Mkomani Clinic Society · U2G · FY2015 · PS

Signal Pathways Modulating HIV-1-induced Injury in CNS

$1,178,170
Shohreh Amini · Temple Univ Of The Commonwealth · P01 · FY2006 · NS

The National Drug Abuse Clinical Trials Network: New England Consortium Node

$1,178,145
Gail D'onofrio · Yale University · UG1 · FY2021 · DA

Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in Lymphoma

$1,178,126
Douglas F Nixon · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA

Virologic Correlates of Heterosexual Transmission

$1,178,079
Eric Hunter · Emory University · R01 · FY2021 · AI

Cell and Cancer Biology Branch Confocal Microscopy Core

$1,178,054
Yvona Ward · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA

CTL and HIV Polymorphisms in Heterosexual Transmission

$1,178,018
Emory University · R01 · FY2005 · AI

Metabolic regulation of T cell effector function and anti-tumor immunotherapy

$1,177,923
Naomi Taylor · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Structure-based design of novel Lassa virus glycoproteins for vaccine development

$1,177,630
Robert F Garry · Tulane University Of Louisiana · R01 · FY2020 · AI

Zambia Alabama HIV Alcohol Comorbidities Program (ZAMBAMA)

$1,177,489
Karen L Cropsey · University Of Alabama At Birmingham · P01 · FY2021 · AA

HIV-1 SHEDDING FROM FEMALE GENITAL TRACT

$1,177,191
University Of Washington · P01 · FY2002 · HD

Western New England Maternal Pediatric Adolescent AIDS Clinical Trials Unit

$1,177,164
Katherine F Luzuriaga · Univ Of Massachusetts Med Sch Worcester · U01 · FY2007 · AI